血小板缺陷是可修饰的假体周围感染风险因素:临床前小鼠模型研究
本研究在小鼠假体周围感染(PJI)模型中,用抗CD41抗体诱导血小板减少症(TCP),评估其对宿主抗菌防御的影响。体外实验显示血小板去除的全血杀菌能力显著下降,回输未处理血小板可逆转;体内实验显示TCP小鼠感染负荷显著更高,且与术前血小板计数负相关(r²=0.63,p=0.037),术后第28天植入物及假体周围组织细菌CFU增加。结论提示血小板减少增加PJI细菌负荷,血小板数量或功能缺陷是骨科患者可修饰的PJI风险因素。
要点
- 血小板减少症小鼠在PJI模型中感染负荷显著高于对照。
- 体外血小板去除全血杀菌能力下降,回输血小板可恢复。
- 术前血小板计数与感染负荷负相关(r²=0.63,p=0.037)。
核心结论
- 在小鼠PJI模型中,血小板减少症导致体外和体内细菌负荷均增加。
- 骨科患者血小板数量或功能缺陷是易于修饰的PJI风险因素。
研究设计与样本
- 临床前小鼠模型研究:C57BL/6小鼠用抗CD41抗体诱导血小板减少症(TCP)。
- 体外将预处理小鼠全血与金黄色葡萄球菌孵育,评估抗菌效力。
- 体内将载有生物发光Xen36金黄色葡萄球菌的钛植入物置入股骨,纵向成像并术后第28天CFU定量。
- 平行设置未处理异体血小板回输以评估抗菌效力挽救。
主要发现
- 抗CD41处理导致血小板计数显著剂量依赖性下降。
- 体外血小板去除全血细菌减少显著少于对照血,回输未处理血小板可逆转。
- 体内TCP小鼠感染负荷显著更高,且与术前血小板计数负相关(r²=0.63,p=0.037)。
- 术后第28天CFU定量显示TCP小鼠细菌增殖和假体周围感染严重程度增加。
关键数值与推荐
- 抗CD41处理导致血小板计数显著剂量依赖性下降。
- 术前血小板计数与感染负荷负相关(r²=0.63,p=0.037)。
临床怎么用
- 骨科患者血小板数量或功能缺陷可作为可修饰的PJI风险因素进行管理。
局限性
- 证据来自临床前小鼠模型,外推至临床需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Well known for their hemostatic function, platelets are increasingly becoming recognized as important immunomodulators. The purpose of the present study was to assess the impact of platelet depletion on antimicrobial host defense in a mouse model of periprosthetic joint infection (PJI). METHODS: Thrombocytopenia (TCP) was induced in C57BL/6 mice with use of a selective antibody against platelet CD41 (anti-CD41). Whole blood from pre-treated mice was incubated with Staphylococcus aureus to assess antimicrobial efficacy with use of bioluminescent imaging, quantitative histological staining, and colony forming unit (CFU) quantification. In parallel, untreated heterologous platelets were added to TCP blood to assess potential rescue of antimicrobial efficacy. In vivo, TCP and control mice underwent placement of a titanium implant in the femur inoculated with bioluminescent Xen36 S. aureus. Longitudinal bioluminescent imaging was performed postoperatively to quantify the evolution of bacterial burden, which was confirmed via assessment of S. aureus CFUs on the implant and in peri-implant tissue on postoperative day (POD) 28. RESULTS: Anti-CD41 treatment resulted in significant dose-dependent reductions in platelet count. Ex vivo, platelet-depleted whole blood demonstrated significantly less bacterial reduction than control blood. These outcomes were reversed with the addition of untreated rescue platelets. In vivo, infection burden was significantly higher in TCP mice and was inversely correlated with preoperative platelet count (r2 = 0.63, p = 0.037). Likewise, CFU quantification on POD28 was associated with increased bacterial proliferation and severity of periprosthetic infection in TCP mice compared with controls. CONCLUSIONS: Thrombocytopenia resulted in an increased bacterial burden both ex vivo and in vivo in a mouse model of PJI. CLINICAL RELEVANCE: In orthopaedic patients, deficiencies in platelet quantity or function represent an easily modifiable risk factor for PJI.
引用
- Greig D, Trikha R, Sekimura T, et al. Platelet Deficiency Represents a Modifiable Risk Factor for Periprosthetic Joint Infection in a Preclinical Mouse Model. J Bone Joint Surg Am. 2021. PMID: 33877055. doi:10.2106/JBJS.20.01428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。